8.2 Cost-effectiveness and health economic implications The elevated cost of acquisition of GLP-1 receptor agonists convey major challenges for healthcare systems, with yearly treatment expenses between $10,000 and $15,000 USD, markedly surpassing those of conventional diabetic drugs (Kong et al
6 power players making decisions on the new FDA committee Several new members of the committee run peptide-selling clinics and promote peptide therapy
We definitely dont know everything, said Skibicka
The key to success lies in consistent use, healthy lifestyle choices, and patience
Improved Sex Drive Insulin-like growth factor has been linked to improved sexual function in both men and women
Mounjaro contains tirzepatide, a medication that mimics two natural gut hormones called GLP-1 and GIP